Stay updated on Brexanolone in COVID-19 ARDS Clinical Trial
Sign up to get notified when there's something new on the Brexanolone in COVID-19 ARDS Clinical Trial page.

Latest updates to the Brexanolone in COVID-19 ARDS Clinical Trial page
- CheckyesterdayChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's status. Updated the page version to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check8 days agoChange DetectedAdded a 'Show glossary' option and a new 'Revision: v3.4.0' label, while older labels such as 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' were removed. These are cosmetic UI and labeling changes and do not affect the study data or core information.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision: v3.3.4 was added to the Study Documents, replacing Revision: v3.3.3. This suggests updated study documents, such as the Protocol and Statistical Analysis Plan, are now referenced on the page.SummaryDifference0.1%

- Check43 days agoChange DetectedNew study locations added across several states (California, Georgia, Massachusetts, Michigan, Nevada, North Carolina, Virginia, and Washington). Existing state location sections were removed.SummaryDifference1.0%

- Check72 days agoChange DetectedRevision note added: v3.3.2. Revision note removed: v3.2.0. No visible changes to study details, eligibility criteria, or page layout.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page no longer displays the government funding operating status notice. It previously directed users to cc.nih.gov and opm.gov for updates.SummaryDifference0.4%

Stay in the know with updates to Brexanolone in COVID-19 ARDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brexanolone in COVID-19 ARDS Clinical Trial page.